Cited by 350Diabetes Management and ResearchPain Mechanisms and TreatmentsDiabetic Foot Ulcer Assessment and Management

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion

Open access

Martin, Catherine L., Albers, James, Herman, William H., Cleary, Patricia, Waberski, Barbara, Greene, Douglas A., Stevens, Martin J., Feldman, Eva L.·2006·Diabetes Care

DOI 10.2337/diacare.29.02.06.dc05-1549PMC PMC2622720

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE—To evaluate the impact of prior intensive diabetes therapy on neuropathy among former Diabetes Control and Complications Trial (DCCT) participants. RESEARCH DESIGN AND METHODS—At the conclusion of the DCCT, subjects in the intensive group were encouraged to maintain intensive therapy, and subjects in the conventional group were encouraged to begin intensive therapy. Thereafter, we annually assessed neuropathy as part of the Epidemiology of Diabetes Intervention and Complications (EDIC) study. Neuropathy was defined using the Michigan Neuropathy Screening Instrument (MNSI). We recorded potential adverse consequences of neuropathy. RESULTS—At the first EDIC examination, 1,257 subjects participated in the neuropathy assessment. Consistent with DCCT results, the former intensive group showed a lower prevalence of neuropathy than the conventional group based on positive questionnaire (1.8 vs. 4.7%; P = 0.003) or examination (17.8 vs. 28.0%; P < 0.0001) results. Despite similar levels of glycemic control, symptoms and signs of neuropathy remained less prevalent among the former intensive group compared with the conventional group. At the beginning of the EDIC study, prior intensive therapy reduced the odds of having symptoms and signs of neuropathy using MNSI criteria by 64% (P = 0.0044) and 45% (P < 0.0001), respectively, with similar odds reductions observed for both neuropathic symptoms (51%, P < 0.0001) and neuropathic signs (43%, P < 0.0001) across 8 years of EDIC follow-up. CONCLUSIONS—The benefits of 6.5 years of intensive therapy on neuropathy status extended for at least 8 years beyond the end of the DCCT, similar to the findings described for diabetic retinopathy and nephropathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/diacare.29.02.06.dc05-1549

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,291
Self-citation
Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic Nephropathy
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2003) · JAMA · doi:10.1001/jama.290.16.2159 · Cited by 1,009
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
(1999) · Diabetes Care · doi:10.2337/diacare.22.1.99 · Cited by 662
The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy
The Diabetes Control and Complications Trial Research Group. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00001 · Cited by 602
Implementation of Treatment Protocols in the Diabetes Control and Complications Trial
Diabetes Control and Complications Trial Research Group (1995) · Diabetes Care · doi:10.2337/diacare.18.3.361 · Cited by 285

Show all 15 references

Sorted by citations

Items 201–300 of 350

Metabolic Memory in the Autonomic Neuropathy of Diabetes
Chaturvedi, N. (2009) · Circulation · doi:10.1161/circulationaha.109.867036 · Cited by 10
Biomarkers and signaling pathways of diabetic nephropathy and peripheral neuropathy: possible therapeutic intervention of rutin and quercetin
Roohi, T. F., Mehdi, S., Aarfi, S., Krishna, K. L., Pathak, S., Suhail, S. M., & Faizan, S. (2023) · Diabetology International · doi:10.1007/s13340-023-00680-8 · Cited by 9
Prevention of Ulceration and Amputation, by Neurolysis of Peripheral Nerves in Diabetics with Neuropathy and Nerve Compression: Decisiontree Utility Analysis
Garrod, K. N. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000330 · Cited by 9
Type 1 diabetes in Cheshire: Cardiometabolic risk factor trends (2004–2009)
Anderson, S. G., Narayanan, R. P., Amlesh, J., Qureshi, M. Z., & Heald, A. H. (2011) · Primary care diabetes · doi:10.1016/j.pcd.2011.10.007 · Cited by 9
On the characterization of a class of fisher-consistent loss functions and its application to boosting
Neykov, M., Liu, J. S., & Cai, T. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 9
Intensive insulin therapy in sepsis patients: Better data enables better intervention
Wang, L., Wang, M., Du, J., & Gong, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14063 · Cited by 9
Significance of functionalGRP78polymorphisms in predicting the onset of type 2 diabetic peripheral neuropathy in Chinese population
Jia, Y., Yu, T., & Min, L. (2015) · Neurological Research · doi:10.1179/1743132815y.0000000054 · Cited by 9
Diabetic Peripheral Neuropathy
Ziegler, D. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch38 · Cited by 10
Pharmacological importance of Bacopa monnieri on Neurological disease (Alzheimer’s Disease) and Diabetic neuropathy - A Concise Review
Karati, D., & Shaw, T. K. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00636 · Cited by 4
Composite nerve conduction scores and signs for diagnosis and somatic staging of diabetic polyneuropathy: Mid North American ethnic cohort survey
Davies, J. L., Lodermeier, K. A., Klein, D. M., Carter, R. E., Dyck, P. J. B., Litchy, W. J., & Dyck, P. J. (2023) · Muscle & Nerve · doi:10.1002/mus.27793 · Cited by 9
Efficacy of pulsed electromagnetic field on pain and nerve conduction velocity in patients with diabetic neuropathy
Battecha, K. H. (2017) · Bulletin of Faculty of Physical Therapy · doi:10.4103/1110-6611.209877 · Cited by 8
Das diabetische Fußsyndrom – Pathogenese, Diagnostik, Therapie und Prävention
Brandl, R., & Stiegler, H. (2015) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0041-101257 · Cited by 8
We have the evidence, we need to act to improve diabetes care
Prato, S. D., Horton, E. S., Nesto, R. W., & Management, O. B. O. T. G. P. F. E. D. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01609.x · Cited by 8
Prandial insulin: is inhaled enough?
Boss, A., Yu, W., & Ellerman, K. E. (2008) · Drug Development Research · doi:10.1002/ddr.20239 · Cited by 8
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_10 · Cited by 9
Pathophysiology and treatment for diabetic neuropathy
Yasuda, H. (2009) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.49.149 · Cited by 8
Diabetes mellitus
Sacks, D. B. (2012) · Tietz Textbook of Clinical Chemistry and Molecular Diagnostics · doi:10.1016/b978-1-4160-6164-9.00046-9 · Cited by 7
Multimodal Approaches in the Treatment of Chronic Peripheral Neuropathy—Evidence from Germany
Romeyke, T., & Stummer, H. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21010066 · Cited by 45
OPTIMIZATION DIABETIC POLYNEUROPATHY PATIENTS MANAGEMENT USING A MULTIDISCIPLINARY APPROACH
Parfenov, V. A., Golovacheva, V. A., Fadeev, V. V., Volovik, A. Y., & Александровна, Г. А. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-0-71-79 · Cited by 7
Bayesian profiling multiple imputation for missing hemoglobin values in electronic health records
Si, Y., Palta, M., & Smith, M. A. (2020) · The Annals of Applied Statistics · doi:10.1214/20-aoas1378 · Cited by 7
Serum neuron-specific enolase as a biomarker in diagnosing diabetic peripheral neuropathy: A cross-sectional study
Kandasamy, S., Krishnan, B., Gopalakrishnan, S., & Ganesan, H. (2022) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v13i12.46183 · Cited by 7
Peripheral and Autonomic Neuropathy in Diabetes
Pop‐Busui, R., Boulton, A. J. M., & Sosenko, J. M. (2018) · Cited by 7
A call to action - the UN Resolution on diabetes
Prato, S. D. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01607.x · Cited by 7
Metabolic Memory in Diabetes Is True Long-term Memory
Frank, R. N. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2008.607 · Cited by 7
The impact of obstructive sleep apnea treatment on microvascular complications in patients with type 2 diabetes: a feasibility randomized controlled trial
Makhdom, E. A., Maher, A., Ottridge, R. S., Nicholls, M., Ali, A., Cooper, B. G., Ajjan, R., Bellary, S., Hanif, W., Hanna, F., et al. (2024) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.11020 · Cited by 6
Frequency and determinants of subclinical neuropathy in type 1 diabetes mellitus
Fahmi, R. M., Altaweel, Y. A., Shehta, N., Elserafy, T. S., Allam, H. M., & Elsaid, A. F. (2016) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.4103/1110-1083.202383 · Cited by 6
Diabetische Neuropathie
Lechleitner, M., Abrahamian, H., Francesconi, C. M., & Köfler, M. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0930-4 · Cited by 6
Proficiency Testing of Hb A1c: A 4-Year Experience in Taiwan and the Asian Pacific Region
Shiesh, S., Wiedmeyer, H.-M., Kao, J., Vasikaran, S. D., & Lopez, J. B. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.129726 · Cited by 6
Review: Microvascular complications: evaluation and monitoring relevance to clinical practice, clinical trials, and drug development
Greenstein, A. S., Tavakoli, M., Mojaddidi, M. A., Alsunni, A. A., Matfin, G., & Malik, R. A. (2007) · The British Journal of Diabetes · doi:10.1177/14746514070070040501 · Cited by 5
Successive detection of glucose and bio-copper in human serum based on a multiplex biosensor of gold nanorods
Chen, S., Zhao, Q., Zhang, L., Xia, X., & Huang, H. (2014) · Analytical Methods · doi:10.1039/c4ay02722a · Cited by 5
3. Diabetic Neuropathies
Baba, M. (2009) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.98.779 · Cited by 5
Neurological Features and Their Association With Gender in Diabetes Mellitus Patients
Mubeen, M., Masood, A., Khan, M. U., Chohan, H. K., Jamal, A., Chohan, M. K., Abbassey, S. S., Anwar, A., & Hashmi, A. A. (2023) · Cureus · doi:10.7759/cureus.39687 · Cited by 5
Management of painful diabetic neuropathy: What is new or in the pipeline for 2007?
Ziegler, D. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0068-5 · Cited by 5
Is Stem Cell Transplantation Ready for Prime Time in Diabetic Polyneuropathy?
Mizukami, H., & Yagihashi, S. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0776-9 · Cited by 5
Cardiac Autonomic Neuropathy in Diabetes Mellitus Patients – Are We Aware of the Consequences?
Moțățăianu, A., Bărcuţean, L., Maier, S., Bălașa, A. F., & Stoian, A. (2020) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2020-0003 · Cited by 5
Frequency of Neuropathic Sensory Symptoms Among Patients With Uncontrolled Diabetes Mellitus in Security Forces Hospital, Riyadh, Saudi Arabia
Alamri, A., Alharbi, K. K., Hassan, K., Alhakami, S., Alosaimi, M. A., Rofidi, K., & Ahmed, I. (2021) · Cureus · doi:10.7759/cureus.17528 · Cited by 5
Diabetes: glycaemic control in type 1.
Leelarathna, L., Guzder, R., Muralidhara, K., & Evans, M. L. (2011) · Europe PMC (PubMed Central) · Cited by 5
Pedal osteomyelitis in patients with diabetes: a retrospective audit from Saudi Arabia
Malone, M., Gannass, A. A., Descallar, J., Bowling, F. L., & Dickson, H. G. (2013) · Journal of Wound Care · doi:10.12968/jowc.2013.22.6.318 · Cited by 5
Aggregate Cardiovascular Risk Is a Stronger Statistical Correlate of Clinically Evident Diabetic Peripheral Neuropathy Than HbA1c Alone
Owolabi, M. O., Ipadeola, A., & Adeleye, J. O. (2010) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30656-8 · Cited by 7
Diabetic Peripheral Neuropathy: Current Concepts and Future Perspectives
Saxena, A. K., Nath, S., & Kapoor, R. (2015) · Cited by 5
Treatment of Diabetic Neuropathy
Pop‐Busui, R., Simmons, Z., & Feldman, E. L. (2010) · Wiley eBooks · doi:10.1002/9780470682807.ch19 · Cited by 5
Self-citation
Effect of Phytochemicals on Diabetes‐Related Neurological Disorders
Mohammed, A., Pandey, K. B., & Rizvi, S. I. (2017) · doi:10.1002/9781119155195.ch13 · Cited by 5
Haemoglobin A 1c in the diagnosis and monitoring of diabetes mellitus
Kilpatrick, E. S., Royal, H., & Hu, H. (2008) · Cited by 4
Protective effects of CHIP overexpression and Wharton's jelly mesenchymal‐derived stem cell treatment against streptozotocin‐induced neurotoxicity in rats
Ju, D., Thao, D. V., Lu, C., Ali, A., Shibu, M. A., Chen, R., Day, C. H., Shih, T., Tsai, C., Kuo, C., et al. (2022) · Environmental Toxicology · doi:10.1002/tox.23544 · Cited by 4
An Insight into the Development of Potential Antidiabetic Agents along with their Therapeutic Targets
Tiwari, S., Kaur, P., Gupta, D., Chaudhury, S., Chaudhary, M., Mittal, A., Kumar, S., & Sahu, S. K. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230522112758 · Cited by 5
Who should benefit from diabetes cell therapy?
Vantyghem, M., Balavoine, A.-S., Kerr-Conte, J. A., Pattou, F. N., & Noël, C. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.08.002 · Cited by 4
Current Treatments in the Management of Diabetic Peripheral Neuropathic Pain 2009
Kuritzky, L., Samraj, G. P. N., & Argoff, C. E. (2008) · Cited by 4
Vascular endothelial growth factor gene transfer for diabetic polyneuropathy
Kessler, J. A. (2009) · Annals of Neurology · doi:10.1002/ana.21686 · Cited by 3
The Relation between Distal Symmetrical Polyneuropathy Severity and HbA1c Level of Patients Diagnosed as Type 2 Diabetes Mellitus
Yıldırım, A., Gulen, H. K. A., Güngen, B. D., Yağız, O., Saçak, Ş., & Polat, H. (2014) · Istanbul Medical Journal · doi:10.5152/imj.2014.98853 · Cited by 3
Clinical applications of glycosylated haemoglobin
Reddy, S. A., Sachan, A., SrinivasaRao, P. V. L. N., & Mohan, A. (2013) · The Journal of Clinical and Scientific Research · doi:10.15380/2277-5706.jcsr.12.068 · Cited by 3
Oxidative stress and diabetes
Agrawal, N. K., Singh, S. K., Singh, N., Kalra, S., & Srivastava, G. (2010) · The Internet Journal of Geriatrics and Gerontology · doi:10.5580/981 · Cited by 5
Diabetes: glycaemic control in type 1.
Srinivasan, B., Davies, M. J., & Lawrence, I. G. (2008) · PubMed Central · Cited by 3
Diabetes mellitusun tanı ve izlem kriterleri
Atmaca, A. (2012) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm.omu.29.s1.002 · Cited by 3
Objectifs du contrôle de la glycémie
Imran, S. A., RABASA-LHORET, R. P. R., & Ross, S. A. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.036 · Cited by 3
Evaluation of median nerve in children with type1 diabetes using ultrasonographic imaging and electrophysiology
Refaat, R., Abdelhameed, A. M., Elbarbary, N. S., & Hilaly, R. E. (2013) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1016/j.ejrnm.2013.06.002 · Cited by 3
Risk of diabetic foot ulceration during treatment with insulin glargine and NPH insulin
Kostev, K., Dippel, F. W., Rockel, T., & Siegmund, T. (2012) · Journal of Wound Care · doi:10.12968/jowc.2012.21.10.483 · Cited by 3
Diabetes Mellitus
Boulton, A. J. M., & Malik, R. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00053-8 · Cited by 3
Exercise for diabetic neuropathy: A toe in the therapeutic door
Smith, A. G., & Marcus, R. L. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.005 · Cited by 3
Reviewers Who Completed a Review During 2008
(2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2008.578 · Cited by 3
PREVALENCE OF SUBCLINICAL PERIPHERAL NEUROPATHY BY NERVE CONDUCTION STUDY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
Govindasamy, P., Devarajan, V., Manivannan, M., Angamuthu, V. J., Krishnan, M., & Sengottuvelu, S. (2019) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2019/478 · Cited by 2
The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy
Kostourou, D.-T., Milonas, D., Polychronopoulos, G., Sofogianni, A., & Τζιόμαλος, Κ. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081253 · Cited by 3
Advanced Glycation End Products Inhibitor
Dan, T., de Strihou, C. V. Y., & Miyata, T. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_20 · Cited by 2
Die diabetische Neuropathie
Lechleitner, M., Abrahamian, H., & Francesconi, M. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0267-1 · Cited by 2
Diabetic Neuropathy: Determining the Sensitivity of Peripheral Nerves During a Short Course of Glycemic Control
Moghtaderi, A., Alavi-Naini, R., Mohammadi, M., & Rashidi, H. (2006) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2006.818.822 · Cited by 2
Gangliosides for the treatment of diabetic peripheral neuropathy
Mallik, S., Kallis, C., Lunn, M. P., & Smith, A. G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011028.pub2 · Cited by 2
PATHOGENESIS OF DIABETIC NEPHROPATHY AND POTENTIAL THERAPEUTIC EFFECT OF CURCUMIN: A REVIEW
Arya, A., & Singh, A. D. L. (2013) · International Journal of Pharma and Bio Sciences · Cited by 2
A holistic approach to the management of a neuropathic plantar ulcer
McCluskey, S., & Gooday, C. (2008) · Journal of Wound Care · doi:10.12968/jowc.2008.17.4.28838 · Cited by 2
Variability in Insulin Action: Mechanisms, Implications, and Recent Advances
(2007) · The Internet Journal of Family Practice · doi:10.5580/173f · Cited by 2
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neuman, S. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-1 · Cited by 2
La infermeria d'atenció primària en l'atenció als problemes del peu en la diabetis tipus 2 a Catalunya
Jurado, J. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Glycaemic control: evaluation of HbA1c as a risk factor and the effect of modern insulins in clinical practice
Lind, M. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
WITHDRAWN: Targets for Glycemic Control
Imran, S. A., RABASA-LHORET, R. P. R., & Ross, S. A. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.04.008 · Cited by 4
Retracted
Gangliosides for the treatment of diabetic peripheral neuropathy
Mallik, S., Kallis, C., Lunn, M. P., & Smith, A. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011028 · Cited by 2
Retracted
Nursing Management and Integrative/Integrated Applications in Diabetic Neuropathy
GÜNDOĞAN, R., & Bağlama, S. S. (2022) · Sakarya Üniversitesi Holistik Sağlık Dergisi · doi:10.54803/sauhsd.1150292 · Cited by 1
Autonomic function and hemodynamic changes in type 2 diabetes: insights into sympathetic activation and vascular stiffness
da Costa, L. M. C., Minari, T. P., Pisani, L. P., Rubio, T. D. A., Yugar, L. B. T., Sedenho‐Prado, L. G., Ribeiro, M., Tácito, L. H. B., Cosenso‐Martin, L. N., Pires, A. C., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112266 · Cited by 1
Diabeticheskaya distal'naya polineyropatiya
Demidova, I. Y., Николаевич, Х. В., & Игнатова, О. Ю. (2008) · Endocrine Surgery · doi:10.14341/2306-3513-2008-1-29-39 · Cited by 1
Diabetic Neuropathy in Black Sub-Saharian Africa Subject: Clinical and Electromyographic Fealures
Tour, M., Didhiou, D., Basse, A., El Mountassir, M., Seck, B., Diaw, M., Sow, D., Abdoulaye, B., Ndiaye, M., Ndiaye, M., et al. (2015) · Journal of Physiology and Pharmacology Advances · doi:10.5455/jppa.20150810014153 · Cited by 1
La mono-neuropathie phrénique secondaire au diabète : une complication rare
Obbiba, A., Aziz, S. E., Chadli, A., Ghomari, H. E., & Farouqi, A. (2013) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(13)70562-5 · Cited by 1
Diabetes in the Young
Imperatore, G., Linder, B. L., & Pettitt, D. J. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195317060.003.0027 · Cited by 2
Peripheral Neuropathy in Diabetes: Burden, Lifestyle and Pharmacological Interventions for Prevention and Treatment
Fairag, M., Akbar, A. F., Ghasib, A., Alagbari, F., Alzahrani, S., Alshegifi, H., Alamoudi, A. M., Awad, M., Aljohani, R., & Althobaiti, H. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i49b33373 · Cited by 1
Diabetic Neuropathy
Chin, R. L., & Rubin, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_23 · Cited by 1
The Role of Lipids and Lipoproteins in Peripheral Neuropathy
Collazos-Alemán, J. D., Salazar-Ocampo, M. P., & Mendivil, C. O. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_18 · Cited by 1
Diabetic Neuropathy Modulation by Zinc and/or Polyphenol Administration
Bădescu, L., Ciocoiu, M., Badescu, C. M., & Bădescu, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805186-3.00007-2 · Cited by 1
COMPLEX ASSESSMENT OF COMPENSATION IN DIABETES MELLITUS TYPE 1 ACCORDING TO THE RESULTS OF CONTINUOUS GLUCOSE MONITORING
Makhlina, E., Kapliyeva, M. P., Navmenova, Y. L., & Savasteeva, I. (2016) · Health and Ecology Issues · doi:10.51523/2708-6011.2016-13-3-26 · Cited by 1
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_10 · Cited by 1
Therapieoptionen der schmerzhaften diabetischen Polyneuropathie
Archelos, J. J. (2007) · Wiener klinische Wochenschrift · doi:10.1007/s00508-007-0795-2 · Cited by 1
Risk factors for retinopathy in type 1 diabetes
Hietala, K. (2013) · Työväentutkimus Vuosikirja · Cited by 1
Prevention of diabetic microvascular complications
Kong, A. P. S., & Chan, J. C. N. (2015) · doi:10.1002/9781118387658.ch39 · Cited by 1
Arterial Stiffness in Type 2 Diabetes Patients in Ghana
Yeboah, K. (2013) · Cited by 1
Preclinical Symptoms of the Diabetic Foot
Bekler, H., & Ertav, A. (2009) · Journal of the American Podiatric Medical Association · doi:10.7547/0980114 · Cited by 1
Gastrointestinal and Autonomic Complications of Diabetes Mellitus
Vella, A. V., & Camilleri, M. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-23 · Cited by 1
Diseño y validación de un procedimiento enfermero de cribado de neuropatía diabética en atención primaria
Alberto, M., & Enrique, C. (2016) · Scientia Insularum Revista de Ciencias Naturales en islas · Cited by 1
Prevalence and spectrum of diabetic peripheral neuropathy and its correlation with insulin resistance - An experience from eastern IndiaPreprint
Majumdar, M., Banerjee, M., Sengupta, J., Deb, S., Jana, C. K., & Roy, B. K. (2020) · medRxiv · doi:10.1101/2020.04.12.20056150 · Cited by 1
Pharmacotherapy in Diabetic Neuropathy
Dejgaard, A., & Hilsted, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_22 · Cited by 1
Insulin Therapy and Hypoglycemia - Present and Future
Cernea, S., Nagar, R., Bitton, G., & Raz, I. (2011) · InTech eBooks · doi:10.5772/24844
The Role of Microvascular Complications in the Relationship between Glycemic Control and Depressive Symptomatology in Patients with Type 1 Diabetes: A Mediational Study
Mayhew, L. L. (2011) · Digital Commons - University of South Florida (University of South Florida)
Metabolic Control Targets for Patients with Type 1 Diabetes in Clinical Practice
María, G., López‐Tinoco, C., Ortego-Rojo, J., & Aguilar‐Diosdado, M. (2011) · InTech eBooks · doi:10.5772/17792
Pharmakotherapie der sensomotorischen Neuropathie
Luft, D. (2008) · Der Diabetologe · doi:10.1007/s11428-008-0261-4
SENSORY NEURON INSULIN SIGNALING AND ITS ROLE IN DIABETIC NEUROPATHY
Grote, C. W. (2013) · KU ScholarWorks (The University of Kansas)
Effects of customary drugs and modified herbal therapy on blood glucose and total antioxidant capacity in Streptozotocin induced diabetes in albino rats: A comparative analysis
Siddiqui, I. A., Hassan, S. H., Ahmed, F., Sarwar, M., & Iqbal, K. (2013) · International Journal of Pharmacology and Toxicology · doi:10.14419/ijpt.v1i1.1017

Authors: Martin, C. L., Albers, J., Herman, W. H., Cleary, P., Waberski, B., Greene, D. A., Stevens, M. J., & Feldman, E. L.
Affiliations: Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Intervention and Complications (EDIC) Research Group
ORCID: Martin, Catherine L.
Stevens, Martin J.
Feldman, Eva L.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2006-02-01
Volume: 29
Issue: 2
Pages: 340-344
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.29.02.06.dc05-1549
PMC: PMC2622720
OpenAlex: W2010740931
Cited by: 350
References: 15
Citations by year: 2026: 4 · 2025: 2 · 2024: 6 · 2023: 14 · 2022: 7 · 2021: 8 · 2020: 14 · 2019: 11 · 2018: 16 · 2017: 16 · 2016: 17 · 2015: 19 · 2014: 30 · 2013: 26 · 2012: 22
FWCI: 20.92
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: Eli Lilly and Company
National Institutes of Health (n01dk062204-003)
National Institute of Diabetes and Digestive and Kidney Diseases (N01 DK062204)
National Center for Research Resources
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
Keywords: diabetic neuropathy, intensive diabetes therapy, Diabetes Control and Complications Trial, Michigan Neuropathy Screening Instrument, glycemic control, long-term follow-up, type 1 diabetes
MeSH terms: Diabetes Mellitus, Type 1, Diabetic Neuropathies, Follow-Up Studies, Health Surveys, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Surveys and Questionnaires

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks